General of the branch

Insured American's Lifetime Healthcare Expenses May Top $700K, According to New Synchrony Research

Retrieved on: 
Monday, November 14, 2022

STAMFORD, Conn., Nov. 14, 2022 /PRNewswire/ -- An insured American with an employer-sponsored health insurance plan can expect to spend more than $320,000 (including insurance premiums and out-of-pocket costs) during his/her adult lifetime, according to new consumer research from Synchrony (NYSE: SYF), a premier consumer financial services company. This number may be more than double — topping $700,000 — for Americans who purchase their own insurance (without employer or government subsidies) or for those who suffer from chronic illnesses such as diabetes, heart disease or cancer.

Key Points: 
  • As a leader in patient financing, we believe it is important to build awareness among consumers of the cost of healthcare over a lifetime."
  • Additionally, the Synchrony Lifetime of Healthcare Costs study suggests many people significantly underestimate their annual healthcare expenditures and do not save for future healthcare costs, leading many to delay recommended medical procedures, often to the detriment of their health.
  • Extrapolated during an adult lifetime, this could mean an estimated $320,000 in individual healthcare costs between the ages of 18 and 79.
  • The Lifetime of Healthcare Costs study was performed by ASQ360 Market Research/Stephens & Associates on behalf of Synchrony.

J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA

Retrieved on: 
Friday, November 11, 2022

SEOUL, South Korea, Nov. 11, 2022 /PRNewswire/ -- J INTS BIO announced on November 9th that it had received approval from the US FDA for its Phase 1/2 clinical trial of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' in patients with advanced non-small cell lung cancer (NSCLC).

Key Points: 
  • 'JIN-A02' is a Novel Orally administered 4th Generation EGFR TKI, which is highly selective and potent against NSCLC harboring C797S double or triple mutations, presenting in either cis or trans forms.
  • J INTS BIO is expecting the first patient to be recruited in the US before the end of the year.
  • 'JIN-A02' is a novel orally administered 4th Generation EGFR TKI targeting C797S mutations in NSCLC.
  • Although 1st, 2nd, and 3rd Generation EGFR TKIs have been used with some success, recurrence occurs in most patients including those on 3rd Generation TKIs such as Osimertinib.

Generational Silver Jewelry Purchases Examined in New Report

Retrieved on: 
Thursday, November 10, 2022

From the wealthy Silent Generation to the Gen Z consumer, every generation has a unique approach to silver jewelry purchases.

Key Points: 
  • From the wealthy Silent Generation to the Gen Z consumer, every generation has a unique approach to silver jewelry purchases.
  • A new Silver Institute Market Trend Report, Trends in Silver Jewelry Purchases, explores the key drivers in jewelry purchase decision making and the characteristics of the silver jewelry consumer and examines silver jewelry purchases among various key demographics.
  • The report takes a deep dive into Millennials and their jewelry spending habits and what motivates them to buy silver jewelry.
  • The report also reviews silver jewelry trends and silvers status versus gold jewelry purchases and concludes with a review of silver jewelry demand post COVID-19.

J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA

Retrieved on: 
Friday, November 11, 2022

SEOUL, South Korea, Nov. 10, 2022 /PRNewswire/ -- J INTS BIO announced on November 9th that it had received approval from the US FDA for its Phase 1/2 clinical trial of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' in patients with advanced non-small cell lung cancer (NSCLC).

Key Points: 
  • 'JIN-A02' is a Novel Orally administered 4th Generation EGFR TKI, which is highly selective and potent against NSCLC harboring C797S double or triple mutations, presenting in either cis or trans forms.
  • J INTS BIO is expecting the first patient to be recruited in the US before the end of the year.
  • 'JIN-A02' is a novel orally administered 4th Generation EGFR TKI targeting C797S mutations in NSCLC.
  • Although 1st, 2nd, and 3rd Generation EGFR TKIs have been used with some success, recurrence occurs in most patients including those on 3rd Generation TKIs such as Osimertinib.

Video: How Veterans' Needs Are Changing Healthcare Today

Retrieved on: 
Tuesday, November 8, 2022

MIAMI, Nov. 8, 2022 /PRNewswire/ -- Each day, US veterans from the Greatest Generation, those who battled in WWII, become a smaller subset of the living veteran population. Service members who fought in the Korean War and Vietnam War are now the largest veteran group requiring care as they near the end of life—and their needs vary significantly from the generation before. In a new video produced by VITAS® Healthcare, veteran clinicians and healthcare professionals describe the changing needs and how care must adapt to meet these needs.

Key Points: 
  • In a new video produced by VITAS Healthcare, veteran clinicians and healthcare professionals describe the changing needs and how care must adapt to meet these needs.
  • There are 5.6M Vietnam War veterans living today, many are nearing the end of life and with highly individualized needs.
  • The Department of Veterans Affairs currently projects that there are 5.6 million Vietnam War veterans living today.
  • Many of these veterans are nearing the end of life and with highly individualized needs.

AM Best Affirms Credit Ratings of Legal & General Group Plc and Its Rated Subsidiaries

Retrieved on: 
Thursday, November 3, 2022

AM Best has affirmed the Long-Term Issuer Credit Rating (Long-Term ICR) of a (Excellent) of the non-operating holding company, Legal & General Group Plc (L&G) (United Kingdom).

Key Points: 
  • AM Best has affirmed the Long-Term Issuer Credit Rating (Long-Term ICR) of a (Excellent) of the non-operating holding company, Legal & General Group Plc (L&G) (United Kingdom).
  • The ratings of LGAS, Banner Life and William Penn factor in their strategic importance to L&G, and their integration within the group.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

MassMutual Consumer Spending & Saving Index: Inflation and Recession Fears Have Americans Looking for Change

Retrieved on: 
Thursday, November 3, 2022

Americans are heading into this holiday season increasingly stressed and less optimistic about the economy, according to the latest Consumer Spending & Saving Index from Massachusetts Mutual Life Insurance Company ( MassMutual ).

Key Points: 
  • Americans are heading into this holiday season increasingly stressed and less optimistic about the economy, according to the latest Consumer Spending & Saving Index from Massachusetts Mutual Life Insurance Company ( MassMutual ).
  • The financial impacts of inflation and the increasing concern about a recession are continuing to put pressure on Americans financing, impacting their optimism and leading them to seek change.
  • Notable findings from the survey include:
    The stress of inflation is increasing, with more Americans changing their spending habits in the face of a worsening economy.
  • The MassMutual Consumer Spending & Saving Index tracks financial outlooks and behaviors in a changing economic environment.

Nuvve Vehicle-to-Grid Tech Receives IEEE Certification for Utility-Scale Communications

Retrieved on: 
Thursday, November 3, 2022

SAN DIEGO, Nov. 3, 2022 /PRNewswire/ -- Nuvve Holding Corp.'s GIVe™ (Grid Integrated Vehicle) vehicle-to-grid (V2G) platform is now a certified product compliant with the IEEE™ 2030.5 SunSpec Common Smart Inverter Profile (CSIP) standard. This certification is the most widely adopted communications standard between Distributed Energy Resources (DER) and enables Nuvve's GIVe V2G platform to connect and communicate with the leading Distributed Energy Resources Management Systems (DERMS). Nuvve chose to utilize Congruence.IQ (C.IQ) software by Tantalus Systems, a smart grid technology company, focused on helping build sustainable utilities, to assist with this certification process.

Key Points: 
  • Nuvve chose to utilize Congruence.IQ (C.IQ) software by Tantalus Systems , a smart grid technology company, focused on helping build sustainable utilities, to assist with this certification process.
  • IEEE CSIP 2030.5 standard is relied upon by utilities to allow communication between DERMS.
  • Nuvve chose Tantalus to facilitate the SunSpec certification process of their innovative V2G bi-directional charging solution due to Tantalus' extensive and proven experience with utility data interoperability.
  • Nuvve and associated logos are among the trademarks of Nuvve and/or its affiliates in the United States, certain other countries and/or the EU.

As Self-Checkout Lanes Multiply at Retail Locations Across the Country, Catalina Study Assesses Impact on Shopper Behavior & Sales

Retrieved on: 
Thursday, November 3, 2022

Catalina initiated its study -- which assessed data from 4.5 billion UPC-level transactions by 245 million consumers accounting for $222 billion in sales in the U.S. in 2021 -- as more retailers make sweeping shifts from manual to SCO lanes to offset shrinking margins from inflation, respond to social distancing protocols triggered by the pandemic, and take advantage of automation technology.

Key Points: 
  • Retailers need to think carefully about the balance of how shoppers use Self Checkout & Manual lanes to maximize sales.
  • For this SCO study, Catalina segmented shopper IDs into three segments: SCO-only, manned checkout-only (MCO), and a hybrid of SCO and manned lanes.
  • Catalina rounded out its SCO study by offering advice to retailers planning their long-term automation strategy for checkout lanes.
  • Catalina is a leader in shopper intelligence and highly targeted in-store, TV, radio, podcast and digital media that personalizes the shopper journey.

Bidgely Partners with NISC to Enhance Customer Experience for Utility Cooperative Members

Retrieved on: 
Wednesday, November 2, 2022

National Information Solutions Cooperative (NISC) has integrated Bidgelys UtilityAI solution into its service platform to enhance customer experience for utility cooperative members.

Key Points: 
  • National Information Solutions Cooperative (NISC) has integrated Bidgelys UtilityAI solution into its service platform to enhance customer experience for utility cooperative members.
  • In addition to driving higher satisfaction for end consumers, this integration further advances NISCs innovation efforts to foster success among utility cooperative members.
  • View the full release here: https://www.businesswire.com/news/home/20221102005202/en/
    National Information Solutions Cooperative (NISC) integrates Bidgelys AI-powered energy insights into service offering to advance innovation efforts for utility cooperative members.
  • To learn more about how Bidgelys UtilityAI solution optimizes grid operations and enhances customer engagement, read NISC Partners With Bidgely to Drive Digital Transformation for Coop Members .